Praluent 61755-0021-02

Generic: Alirocumab

Package NDC

61755-0021-02

Manufacturer: Regeneron Pharmaceuticals, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: December 1, 2020
Listing Expires: December 31, 2026
Application: BLA125559

Need to source Praluent? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Alirocumab	150 mg/mL

Drug Class

PCSK9 Inhibitor [EPC]AntibodiesMonoclonal [CS]

Selected Package

61755-0021-02Selected

2 SYRINGE, GLASS in 1 CARTON (61755-021-02) / 1 mL in 1 SYRINGE, GLASS

Other packages for this product(2)

61755-0021-01

1 SYRINGE, GLASS in 1 CARTON (61755-021-01) / 1 mL in 1 SYRINGE, GLASS

View →

61755-0021-04

1 SYRINGE, GLASS in 1 CARTON (61755-021-04) / 1 mL in 1 SYRINGE, GLASS

View →